Articles from M2 Pharma (April 2, 2020)

Title	Author	Type	Words
Advanced Sterilization Products Qualifies New Protocol for Reprocessing of N95 Masks.			201
Agilent Launches New Class 1 Triple Quadrupole LC/MS System.			295
Alligator Bioscience temporarily halts recruitment of new patients due to COVID-19 pandemic.			204
Aptorum Group Teams with Covar Pharmaceuticals to Investigate at Least 3 Repurposed Drug Candidates.			593
Arena Pharmaceuticals reveals positive top-line data from Phase one etrasimod clinical study.		Clinical report	240
Camurus reports strong Q1 demand for Buvidal.			204
Charles River Laboratories and Deciphex Partner to Enhance Drug Discovery and Development with Digital Pathology.			303
Daiichi Sankyo Submits Application for CAR T Therapy Axicabtagene Ciloleucel for Treatment of Patients with Certain Relapsed/Refractory B-cell Lymphomas in Japan.		Disease/Disorder overview	551
FARXIGA Phase III DAPA-CKD Trial Will Be Stopped Early After Overwhelming Efficacy in Patients with Chronic Kidney Disease.			358
FibroGenesis expands US patent coverage to include fibroblast cell therapy to treat coronavirus ARDS.			169
Immunovia updates on actions taken during COVID-19 pandemic.			207
Intensity Therapeutics Reports Safety Results from First Cohort of the KEYNOTE A10 Combination Clinical Trial of INT230-6 and Keytruda.		Clinical report	642
Macromoltek offers computational de novo antibody design targeting COVID-19.			153
Molecule Holdings' COVID-19 IgG and IgM Rapid Test authorised for distribution.			160
PreCheck Inks Exclusive Distribution Agreements for Coronavirus (COVID-19) PCR Test in Afghanistan, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan.			248
Seneca Biopharma authorises stock options to two employees under Nasdaq Listing Rule 5635(c)(4).			205
Seneca Biopharma names new president and chief operating officer, and chief financial officer.			358
The Leukemia & Lymphoma Society introduces LLS COVID-19 Patient Financial Aid Program.			171
US FDA approves Sevenfact for treatment of adults and adolescents with haemophilia A or B.			264
WONTECH wins FDA clearance for WONTECH SANDRO DUA laser device.			153